
Check out a recap of important pharmacy news you might have missed this week, dispensed in small doses.
Check out a recap of important pharmacy news you might have missed this week, dispensed in small doses.
Acupuncture, a practice with thousands of years of history, has become increasingly accepted in mainstream medicine.
Pharmacist management of chronic conditions can lead to improved patient outcomes.
Findings from a collection of posters at ACCP underscore the critical role of community pharmacies in promoting health equity and providing high-quality, patient-centered care.
James Rider, PharmD, shared his experiences as a pharmacy manager at CVS.
Posters presented at ACCP 2024 revealed gaps in pharmacy students’ understanding of off-label drug applications and identified strengths and weaknesses among pharmacy graduates.
The financial burden of in vitro fertilization (IVF) medications has become increasingly prohibitive, limiting the availability of fertility treatments for many.
Drug Topics sat down with Adam J. James, PharmD, to discuss learnings from his extensive experience at Rite Aid.
As health care systems and the current syndemic continue to evolve, pharmacies are poised to play a crucial role in improving public health.
In case you missed it, this week we had stories about medication-related disaster preparedness, COVID-19 and cardiovascular risks, legal battles over inflated insulin prices, and more.
Check out a recap of important pharmacy news you might have missed this week, dispensed in small doses.
Marstacimab-hncq is the first non-factor and once-weekly treatment available for patients with hemophilia B and promises to reduce the burden of care.
The approval is supported by results from phase 3 multi-regional clinical trials conducted in patients with plaque psoriasis.
Recent research on vitamin D supplementation and respiratory tract infections can help guide pharmacists in counseling patients.
The partnership will provide tools to address both patient and pharmacist well-being amid the current mental health crisis.
The therapy’s Prescription Drug User Fee Act date has been set for July 26, 2025.
Two posters presented at the annual meeting of the American College of Chest Physicians, CHEST 2024, offered insights into the accurate diagnosis and appropriate treatment of ACOS.
Adherence interventions and comprehensive reviews can reduce health care costs, boost revenue, and improve patient outcomes.
Florida-based pharmacist Brad Phillips, PharmD, BCACP, speaks to the importance of pre-planning, emergency refills, medication storage, and post-storm safety measures to ensure medication security during hurricanes.
Research presented at CHEST 2024 outlined the heart failure risks associated with COVID-19 infection and emphasized the importance of vaccination to prevent adverse outcomes.
Whether patients present with complaints of an aching muscle from a workout or a sudden twinge in the back, consider recommending these topical analgesics.
In case you missed it, this week we had stories about the availability of the first liquid nonstimulant for ADHD, pharmacy technicians as "vaccine champions," SGLT2i's heart-healthy benefits, and more.
Check out a recap of important pharmacy news you might have missed this week, dispensed in small doses.
Social pressures, physiological changes, mental health challenges, and burnout all complicate diabetes management among adolescents.
Many public health officials aren’t surprised by the decline in vaccine coverage, although its underlying causes present unique challenges.
See what’s trending in pharmacy with a preview of the Drug Topics September/October issue.
The Heart Failure Society of America 2024 Annual Meeting featured presentations exploring the benefits of sodium-glucose cotransporter 2 inhibitors (SGLT2i) for patients with heart failure.
Research presented at the Heart Failure Society of America 2024 Annual Meeting demonstrated that glucagon-like peptide 1 receptor agonists (GLP-1 RAs) reduced cardiovascular events in patients without diabetes.
Investigators suggested that the future cost-effectiveness of respiratory syncytial virus (RSV) vaccination could be improved through lower vaccine prices and longer-lasting protection.
In case you missed it, this week we had stories about pharmacists overcoming substance use disorder, the first new treatment approved for schizophrenia in decades, the Senate-Novo Nordisk hearing on semaglutide prices, and more.